Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.31)
# 1,396
Out of 4,413 analysts
102
Total ratings
41.89%
Success rate
-2.23%
Average return
Main Sectors:
27 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: In-Line | $92 → $89 | $84.67 | +5.11% | 6 | Apr 26, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $72 → $78 | $71.87 | +8.53% | 3 | Apr 25, 2024 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $218 → $199 | $162.57 | +22.41% | 1 | Apr 17, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $125 → $130 | $120.28 | +8.08% | 6 | Apr 4, 2024 | |
| WAT Waters | Maintains: In-Line | $320 → $340 | $309.04 | +10.02% | 5 | Apr 4, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $575 → $610 | $568.72 | +7.26% | 7 | Apr 4, 2024 | |
| SYK Stryker | Maintains: Outperform | $340 → $370 | $336.50 | +9.96% | 3 | Apr 4, 2024 | |
| OSUR OraSure Technologies | Maintains: In-Line | $7 → $6.5 | $5.29 | +22.87% | 1 | Apr 4, 2024 | |
| MTD Mettler-Toledo International | Maintains: In-Line | $1,200 → $1,300 | $1,229.70 | +5.72% | 4 | Apr 4, 2024 | |
| MLAB Mesa Laboratories | Maintains: Outperform | $124 → $130 | $106.08 | +22.55% | 3 | Apr 4, 2024 | |
| HOLX Hologic | Maintains: In-Line | $76 → $78 | $75.77 | +2.94% | 7 | Apr 4, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $93 → $100 | $76.24 | +31.16% | 2 | Apr 4, 2024 | |
| BLCO Bausch + Lomb | Maintains: In-Line | $17 → $17 | $14.54 | +16.92% | 4 | Apr 4, 2024 | |
| AZTA Azenta | Maintains: In-Line | $64 → $60 | $52.46 | +14.37% | 3 | Apr 4, 2024 | |
| AVTR Avantor | Maintains: Outperform | $26 → $28 | $24.23 | +15.56% | 9 | Apr 4, 2024 | |
| ABT Abbott Laboratories | Maintains: Outperform | $120 → $125 | $105.97 | +17.96% | 6 | Apr 4, 2024 | |
| USB U.S. Bancorp | Maintains: In-Line | $46 → $48 | $40.63 | +18.14% | 1 | Mar 28, 2024 | |
| NVCR NovoCure | Maintains: In-Line | $14 → $15 | $12.24 | +22.55% | 6 | Feb 23, 2024 | |
| RVTY Revvity | Upgrades: Outperform | $88 → $125 | $102.47 | +21.99% | 1 | Jan 4, 2024 | |
| ILMN Illumina | Reiterates: Outperform | $240 | $123.05 | +95.04% | 5 | Sep 1, 2023 | |
| MDT Medtronic | Maintains: Outperform | $88 → $100 | $80.24 | +24.63% | 2 | May 25, 2023 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $240 → $270 | $370.62 | -27.15% | 7 | Apr 19, 2023 | |
| BAX Baxter International | Maintains: Outperform | $50 → $48 | $40.37 | +18.90% | 4 | Apr 4, 2023 | |
| BDX Becton, Dickinson and Company | Maintains: Outperform | $280 → $275 | $234.60 | +17.22% | 2 | Apr 4, 2023 | |
| TWST Twist Bioscience | Upgrades: Outperform | $28 → $36 | $31.23 | +15.27% | 2 | Jan 3, 2023 | |
| ENOV Enovis | Initiates: Outperform | $68 | $55.23 | +23.12% | 1 | Sep 12, 2022 | |
| HYPR Hyperfine | Initiates: Outperform | $7 | $0.81 | +764.20% | 1 | May 31, 2022 |
Edwards Lifesciences
Apr 26, 2024
Maintains: In-Line
Price Target: $92 → $89
Current: $84.67
Upside: +5.11%
Boston Scientific
Apr 25, 2024
Maintains: Outperform
Price Target: $72 → $78
Current: $71.87
Upside: +8.53%
J.B. Hunt Transport Services
Apr 17, 2024
Maintains: Outperform
Price Target: $218 → $199
Current: $162.57
Upside: +22.41%
Zimmer Biomet Holdings
Apr 4, 2024
Maintains: In-Line
Price Target: $125 → $130
Current: $120.28
Upside: +8.08%
Waters
Apr 4, 2024
Maintains: In-Line
Price Target: $320 → $340
Current: $309.04
Upside: +10.02%
Thermo Fisher
Apr 4, 2024
Maintains: Outperform
Price Target: $575 → $610
Current: $568.72
Upside: +7.26%
Stryker
Apr 4, 2024
Maintains: Outperform
Price Target: $340 → $370
Current: $336.50
Upside: +9.96%
OraSure Technologies
Apr 4, 2024
Maintains: In-Line
Price Target: $7 → $6.5
Current: $5.29
Upside: +22.87%
Mettler-Toledo International
Apr 4, 2024
Maintains: In-Line
Price Target: $1,200 → $1,300
Current: $1,229.70
Upside: +5.72%
Mesa Laboratories
Apr 4, 2024
Maintains: Outperform
Price Target: $124 → $130
Current: $106.08
Upside: +22.55%
Hologic
Apr 4, 2024
Maintains: In-Line
Price Target: $76 → $78
Current: $75.77
Upside: +2.94%
GE HealthCare Technologies
Apr 4, 2024
Maintains: Outperform
Price Target: $93 → $100
Current: $76.24
Upside: +31.16%
Bausch + Lomb
Apr 4, 2024
Maintains: In-Line
Price Target: $17 → $17
Current: $14.54
Upside: +16.92%
Azenta
Apr 4, 2024
Maintains: In-Line
Price Target: $64 → $60
Current: $52.46
Upside: +14.37%
Avantor
Apr 4, 2024
Maintains: Outperform
Price Target: $26 → $28
Current: $24.23
Upside: +15.56%
Abbott Laboratories
Apr 4, 2024
Maintains: Outperform
Price Target: $120 → $125
Current: $105.97
Upside: +17.96%
U.S. Bancorp
Mar 28, 2024
Maintains: In-Line
Price Target: $46 → $48
Current: $40.63
Upside: +18.14%
NovoCure
Feb 23, 2024
Maintains: In-Line
Price Target: $14 → $15
Current: $12.24
Upside: +22.55%
Revvity
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $102.47
Upside: +21.99%
Illumina
Sep 1, 2023
Reiterates: Outperform
Price Target: $240
Current: $123.05
Upside: +95.04%
Medtronic
May 25, 2023
Maintains: Outperform
Price Target: $88 → $100
Current: $80.24
Upside: +24.63%
Intuitive Surgical
Apr 19, 2023
Maintains: In-Line
Price Target: $240 → $270
Current: $370.62
Upside: -27.15%
Baxter International
Apr 4, 2023
Maintains: Outperform
Price Target: $50 → $48
Current: $40.37
Upside: +18.90%
Becton, Dickinson and Company
Apr 4, 2023
Maintains: Outperform
Price Target: $280 → $275
Current: $234.60
Upside: +17.22%
Twist Bioscience
Jan 3, 2023
Upgrades: Outperform
Price Target: $28 → $36
Current: $31.23
Upside: +15.27%
Enovis
Sep 12, 2022
Initiates: Outperform
Price Target: $68
Current: $55.23
Upside: +23.12%
Hyperfine
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.81
Upside: +764.20%